Abstract
Objective: To compare the efficacy and safety of a 5% lidocaine patch with that of 200mg/d celecoxib in treating chronic axial low back pain (LBP). Design: Multicenter, open-label, parallel-group randomized, active-controlled, pilot study. Setting: Office-based practice. Participants: Adult patients (n=122) with LBP with or without radiation who had average daily pain intensity scores of ≥5 for at least 3 of the 5 days prior to baseline visit (measured by question 5 of the Brief Pain Index [BPI]).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
